A randomised, double blind, placebo controlled, parallell group, phase 1 study to assess the safety, tolerability and pharmacokinetics of single and mutlitple ascending oral doses of AZD9668 in healthy japanese and caucasion volunteers
Study identifier:D0520C00004
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A randomised, double blind, placebo controlled, parallell group, phase 1 study to assess the safety, tolerability and pharmacokinetics of single and mutlitple ascending oral doses of AZD9668 in healthy japanese and caucasion volunteers
Medical condition
pharmacokinetics
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Nov 2007
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
